ArticleOpen forum infectious diseases2018
Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States.
Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
66 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Guideline
- Evaluation of Research Accessibility and Data Elements of HIV Registries.Current HIV research · 2019Pooled it
- Guideline
- Reducing time to differentiated service delivery for newly-diagnosed people living with HIV in Kigali, Rwanda: a pilot, unblinded, randomized controlled trial.BMC health services research · 2024Trial
- Initiation of Antiretroviral Therapy in the Hospital Is Associated With Linkage to Human Immunodeficiency Virus (HIV) Care for Persons Living With HIV and Substance Use Disorder.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Trial
- Patterns of HIV viral suppression in a clinical trial evaluating a contingency management intervention.Journal of applied behavior analysisTrial
- Transforming Human Immunodeficiency Virus Outcomes: Impact of a Rapid Antiretroviral Therapy Model on Linkage to Care and Viral Suppression in Memphis, Tennessee.Open forum infectious diseases · 2026Article
- Cost Considerations for Rapid Start Implementation: Analysis from Seven Rapid Start Provider Sites.AIDS and behavior · 2026Article
- Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024.China CDC weekly · 2026Article
- Temporal Changes in Racial Disparities of HIV Linkage to Care from 2013 to 2020: A Statewide Cohort Analysis.Journal of racial and ethnic health disparities · 2026Article
- BE FASTER Community of Practice to Increase Rapid Initiation of Antiretroviral Therapy in Houston, Texas: A Pre-Post Intervention Study.The Permanente journal · 2025Article
- Outcomes of Rapid Restart Among People With Previously Diagnosed HIV at a Safety-Net HIV Clinic in San Francisco.Journal of acquired immune deficiency syndromes (1999) · 2025Article
- Entering HIV Medical Care With AIDS in the Era of Immediate Access to Antiretroviral Treatment.Journal of acquired immune deficiency syndromes (1999) · 2025Article
- Exploration of implementation determinants and strategies for same-day oral PrEP in community-based organizations and federally qualified health centers.Implementation science communications · 2025Article
- Rapid Start of HIV Antiretroviral Therapy in New York State.AIDS and behavior · 2025Article
- Barriers to Rapid Enrollment and ART Initiation Among U.S. HIV Care Facilities.Journal of acquired immune deficiency syndromes (1999) · 2025Article
- Assessment of Virologic Suppression and Retention in Care 6 Years After Rapid Initiation of Antiretroviral Therapy.Open forum infectious diseases · 2025Article
- Direct collaboration between hospitals and NGOs, an essential tool to reinforce linkage to care in people living with HIV.Scientific reports · 2025Article
- Integrating existing and novel methods to understand organizational context: A case study of an academic-public health department partnership.Annals of epidemiology · 2024Article
- Human immunodeficiency virus/acquired immune deficiency syndrome antiretroviral therapy initiated on the same day in treatment-naïve people with human immunodeficiency virus: A comparative study of efficacy and regimen.Chinese medical journal · 2024Article
6 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRapid entry programs (REPs) improve time to antiretroviral therapy (ART) initiation (TAI) and time to viral suppression (TVS). We assessed the feasibility and effectiveness of a REP in a large HIV clinic in Atlanta, Georgia, serving a predominately un- or underinsured population.
methodsThe Rapid Entry and ART in Clinic for HIV (REACH) program was implemented on May 16, 2016. We performed a retrospective cohort study with the main independent variable being period of enrollment: January 1, 2016, through May 15, 2016 (pre-REACH); May 16, 2016, through July 31, 2016 (post-REACH). Included individuals were HIV-infected and new to the clinic with detectable HIV-1 RNA. Six-month follow-up data were collected for each participant. Survival analyses were conducted for TVS. Logistic and linear regression analyses were used to evaluate secondary outcomes: attendance at first clinic visit, viral suppression, TAI, and time to first attended provider visit.
resultsThere were 117 pre-REACH and 90 post-REACH individuals. Median age (interquartile range [IQR]) was 35 (25-45) years, 80% were male, 91% black, 60% men who have sex with men, 57% uninsured, and 44% active substance users. TVS decreased from 77 (62-96) to 57 (41-70) days (
conclusionsThis is the largest rapid entry cohort described in the United States and suggests that rapid entry is feasible and could have a positive impact on HIV transmission at the population level.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.